ArticleCardiology plus

Association between immune checkpoint inhibitors and adverse cardiovascular events in patients with coronary artery disease and malignant tumors: a retrospective cohort study.

Ran Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.